Libido imbroglio

Fate of so-called “female Viagra” to be decided by FDA this week

A little more than two months after an expert Food and Drug Administration panel recommended the approval of flibanserin, a so-called “Viagra for women,” the FDA is set to rule on the drug’s fate this week. It will be the third time in five years the FDA has considered approving flibanserin. The previous two times, the agency declined to approve it on the grounds that the drug’s risks and weaknesses outweigh its benefits — outcomes that have ignited fierce debate in the lead-up to the drug’s third time before the FDA. Many critics of the FDA believe sexism has been behind the drug’s two rejections, but not everyone agrees. Writing in The Washington Post, a “pro-sex feminist” declared that claims of sexism have been a distraction to the decision makers who are charged with approving drugs that are safe and effective.

Read the full story at USA Today.

Related:
What you need to know about flibanserin
Real women answer: Do you discuss your libido?
Could the new “female viagra” threaten asexuals’ identity?

Leave a Reply

Your email address will not be published. Required fields are marked *